Clik here to view.
Aliskiren containing Medications Drug Safety Comunication
Aliskiren-containing Medications: Drug Safety Comunication – New Warning and Contraindication including: Amturnide (aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide) Tekturna...
View ArticleClik here to view.
Ampyra dalfampridine drug risks
Drug Safety Communication – Seizure Risk for Multiple Sclerosis Patients AUDIENCE: Neurology, Internal Medicine ISSUE: FDA is updating health care professionals and the public about the risk of...
View ArticleClik here to view.
Xyrem sodium oxybate Drug Safety Communication
Xyrem (sodium oxybate): Drug Safety Communication – Warning Against Use With Alcohol or Drugs Causing Respiratory Depression AUDIENCE: Neurology, Internal Medicine, Patient ISSUE: FDA reminded...
View ArticleClik here to view.
Incivek telaprevir Drug Safety Communication
Incivek (telaprevir) In Combination with Drugs Peginterferon Alfa and Ribavirin (Incivek Combination Treatment): Drug Safety Communication – Serious Skin Reactions AUDIENCE: Internal Medicine,...
View ArticleClik here to view.
Nizoral ketoconazole Drug Safety Communication
Nizoral (ketoconazole): Drug Safety Communication – Potentially Fatal Liver Injury, Risk of Drug Interactions and Adrenal Gland Problems AUDIENCE: Internal Medicine, Infectious Disease ISSUE: FDA is...
View Article
